Riskpilot← Back to searchSign inGet full accessAWA Läkarkonsult AB
ABActiveOrg 5591386742Primusgatan 67Medical specialists activities · NACE 8622Est. 20171 employees
Revenue 2025
SEK 0
EBITDA margin
—
-113% vs 2024
Equity ratio
88.9%
Financial strength
Net profit 2025
SEK 2K
-99% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -26K | -113% |
| Net profit | SEK 2K | -99% |
| Total assets | SEK 1M | -16% |
| Equity | SEK 919K | +0% |
| Employees | 1 | — |
Legal name
AWA Läkarkonsult AB
Org number
5591386742
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
11 december 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkartjänster samt därmed förenlig verksamhet.
Address
Primusgatan 67
Email
aetwandel@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 573 | 1 585 | 550 | 0 |
| Staff expenses | — | −145 | −963 | −315 | −0 |
| EBITDA | −29 | 398 | 571 | 195 | −26 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −29 | 398 | 571 | 195 | −26 |
| Net financials | — | −2 | 3 | 18 | 13 |
| Profit before tax | −29 | 396 | 574 | 161 | −3 |
| Tax | −0 | −82 | −118 | −32 | −1 |
| Net profit | −29 | 314 | 456 | 129 | 2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 465 | 784 | 1 393 | 1 227 | 1 033 |
| Equity | 381 | 574 | 910 | 918 | 919 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 84 | 209 | 483 | 257 | 79 |
| Total debt | 84 | 209 | 483 | 257 | 79 |
EBITDA margin
-2623500.0%
This company
15.8%
Market median
-16604530% vs market
20212025
Equity ratio
88.9%
This company
38.2%
Market median
+133% vs market
20212025
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
20212025
Net profit margin
192100.0%
This company
8.1%
Market median
+2371505% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AWA Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tore Gunnar Wandel | Deputy Board Member | 0 companies |
| Anne Elisabeth Thérese Wandel | Board of Directors | 0 companies |